Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system for people with Type 2 diabetes using basal insulin. The company also ...

The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping the core price target effectively stable in absolute terms. That tiny shift ...

Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) confirmed the launch of its most advanced generation stent, XIENCE Skypoint, ...

Abbott stock skidded Wednesday after the S&P 500 health giant missed the Street's third-quarter sales forecast, but met earnings expectations and reiterated its full-year guidance. The sales miss is ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...